Safety, Efficacy and Pharmacokinetic Study of PRLX 93936 in Patients With Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01695590
Recruitment Status : Unknown
Verified May 2013 by Prolexys Pharmaceuticals.
Recruitment status was:  Recruiting
First Posted : September 28, 2012
Last Update Posted : June 4, 2013
Information provided by (Responsible Party):
Prolexys Pharmaceuticals

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : March 2014
  Estimated Study Completion Date : September 2014